Neuberger Berman Group LLC lowered its stake in shares of Nutrien Ltd. (NYSE:NTR – Get Rating) by 3.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,266,446 shares of the company’s stock after selling 46,212 shares during the period. Neuberger Berman Group LLC owned about 0.23% of Nutrien worth $131,764,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Hardy Reed LLC purchased a new stake in shares of Nutrien during the first quarter worth about $27,000. Covestor Ltd purchased a new stake in shares of Nutrien during the first quarter worth about $30,000. Northern Oak Wealth Management Inc. increased its stake in shares of Nutrien by 57.4% during the fourth quarter. Northern Oak Wealth Management Inc. now owns 417 shares of the company’s stock worth $31,000 after purchasing an additional 152 shares in the last quarter. Zions Bancorporation N.A. increased its stake in shares of Nutrien by 55.2% during the first quarter. Zions Bancorporation N.A. now owns 301 shares of the company’s stock worth $31,000 after purchasing an additional 107 shares in the last quarter. Finally, Allworth Financial LP acquired a new position in Nutrien during the first quarter worth about $39,000. Hedge funds and other institutional investors own 63.51% of the company’s stock.
Nutrien Stock Performance
Shares of NTR stock opened at $86.06 on Friday. The firm’s 50 day moving average price is $86.93 and its 200-day moving average price is $93.22. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.75 and a current ratio of 1.21. Nutrien Ltd. has a one year low of $60.60 and a one year high of $117.25. The firm has a market cap of $46.41 billion, a P/E ratio of 6.96, a P/E/G ratio of 0.70 and a beta of 0.90.
Nutrien Dividend Announcement
Analyst Ratings Changes
A number of research firms recently weighed in on NTR. Piper Sandler boosted their price target on shares of Nutrien from $112.00 to $125.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 31st. Scotiabank upgraded shares of Nutrien from a “sector perform” rating to a “sector outperform” rating and lowered their price target for the stock from $118.00 to $110.00 in a research report on Tuesday, August 9th. Barclays lowered their price target on shares of Nutrien from $126.00 to $105.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 10th. TD Securities lowered their price target on shares of Nutrien from $130.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, July 29th. Finally, Credit Suisse Group boosted their price target on shares of Nutrien from $67.00 to $70.00 and gave the stock an “underperform” rating in a research report on Thursday, August 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and an average target price of $108.75.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.
- Get a free copy of the StockNews.com research report on Nutrien (NTR)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.